Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
C-X-C motif chemokine ligand 2 | 0.513 | 0.885 | 3.6E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
activating transcription factor 6 | 0.516 | 0.846 | 3.2E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 7 | 2011 | 2011 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
CD5 molecule like | 0.593 | 0.846 | 4.2E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
Ras like without CAAX 1 | 0.527 | 0.808 | 0.13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
Fc receptor like 3 | 0.612 | 0.769 | 6.0E-21 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
interferon gamma inducible protein 16 | 0.603 | 0.769 | 1.8E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 7 | 2011 | 2019 | ||||||||
|
discoidin domain receptor tyrosine kinase 2 | 0.541 | 0.769 | 0.55 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2011 | 2019 | ||||||||
|
absent in melanoma 2 | 0.521 | 0.769 | 2.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 11 | 2011 | 2019 | ||||||||
|
atypical chemokine receptor 1 (Duffy blood group) | 0.608 | 0.731 | 2.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2011 | 2019 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
dynein cytoplasmic 2 heavy chain 1 | 0.555 | 0.731 | 1.1E-44 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
transmembrane serine protease 6 | 0.584 | 0.654 | 4.1E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 10 | 0.599 | 0.654 | 0.15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
limbic system associated membrane protein | 0.558 | 0.654 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
cyclin D3 | 0.554 | 0.654 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2019 | |||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
transferrin receptor 2 | 0.585 | 0.615 | 1.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
Bardet-Biedl syndrome 9 | 0.615 | 0.577 | 4.2E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2018 |